News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pro Top & Mediking Company Limited Announces The First And Revolutionary Collagen Matrix To Prevent Scar Formation For Glaucoma Filtration Microsurgery



10/19/2005 5:12:28 PM

TAIPEI, Taiwan--(BUSINESS WIRE)--Dec. 14, 2004--Mediking Company today announces the successful development of OculusGen -- the scarring inhibitor for glaucoma filtration microsurgery & ophthalmic surgery. A biodegradable 3-dimensional porous collagen-glycosaminoglican scaffold, OculusGen is designed to prevent scar formation and to create a physiological aqua buffer environment for modulating the trabeculectomy and other ophthalmic surgery. Please visit www.OculusGen.com for more information.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES